CTRI Number |
CTRI/2021/05/033344 [Registered on: 04/05/2021] Trial Registered Prospectively |
Last Modified On: |
03/05/2021 |
Post Graduate Thesis |
Yes |
Type of Trial |
Interventional |
Type of Study
|
Drug Surgical/Anesthesia Other (Specify) [CO2 laser] |
Study Design |
Randomized, Parallel Group, Multiple Arm Trial |
Public Title of Study
|
Comparison between treatment of fungal infection of nail by laser and surgery |
Scientific Title of Study
|
Comparative evaluation of efficacy of ‘urea application followed by CO2 laser ablation’ and ‘nail avulsion’ as an adjuvant to conventional therapy in treatment of Onychomycosis. |
Trial Acronym |
|
Secondary IDs if Any
|
Secondary ID |
Identifier |
NIL |
NIL |
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
Name |
Dr Drishti Rajde |
Designation |
1st year resident doctor |
Affiliation |
GCS Medical College, Hospital and Research Centre |
Address |
OPD 35,GCS Medical College, Hospital and Research Centre, Opp DRM office, Naroda road
Ahmadabad GUJARAT 380025 India |
Phone |
9978926129 |
Fax |
|
Email |
drdrishtirajde@gmail.com |
|
Details of Contact Person Scientific Query
|
Name |
Dr Ranjan Raval |
Designation |
Professor and HOD of Dept of Skin and V.D. |
Affiliation |
GCS Medical College, Hospital and Research Centre |
Address |
OPD 35,GCS Medical College, Hospital and Research Centre, Opp DRM office, Naroda road
Ahmadabad GUJARAT 380025 India |
Phone |
9978926129 |
Fax |
|
Email |
ranjanmb@yahoo.com |
|
Details of Contact Person Public Query
|
Name |
Dr Drishti Rajde |
Designation |
1st year resident doctor |
Affiliation |
GCS Medical College, Hospital and Research Centre |
Address |
OPD 35,GCS Medical College, Hospital and Research Centre, Opp DRM office, Naroda road
Ahmadabad GUJARAT 380025 India |
Phone |
9978926129 |
Fax |
|
Email |
drdrishtirajde@gmail.com |
|
Source of Monetary or Material Support
|
|
Primary Sponsor
|
Name |
GCS Medical College Hospital and Research Centre |
Address |
GCS Medical College, Hospital and Research Centre, opp DRM office, Naroda road, Saraspur 380025 |
Type of Sponsor |
Private medical college |
|
Details of Secondary Sponsor
|
|
Countries of Recruitment
|
India |
Sites of Study
|
No of Sites = 1 |
Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
Dr Drishti Rajde |
GCS Medical College, Hospital and Research Centre |
OPD-35, Dept of Dematology, Ground Floor, OPD area Ahmadabad GUJARAT |
9978926129
drdrishtirajde@gmail.com |
|
Details of Ethics Committee
|
No of Ethics Committees= 1 |
Name of Committee |
Approval Status |
Institutional Ethics Committee, GCS Medical College, Hospital and Research Centre |
Approved |
|
Regulatory Clearance Status from DCGI
|
|
Health Condition / Problems Studied
|
Health Type |
Condition |
Patients |
(1) ICD-10 Condition: L608||Other nail disorders, (2) ICD-10 Condition: O||Medical and Surgical, |
|
Intervention / Comparator Agent
|
Type |
Name |
Details |
Comparator Agent |
Conventional therapy |
Oral Itraconazole pulse therapy (200mg BD for 7 days per month) for 2-3 months for finger nails and for 3-4 months for toe nails.
+
Topical Amrolfine 5% nail lacquer once a week for 6 months for finger nails and for 9 months for toe nails.
|
Intervention |
Nail avulsion as an adjuvant to conventional therapy
|
The affected nail is avulsed. Then the patient is given oral Itraconazole pulse therapy (200mg BD for 7 days per month) for 2-3 months for finger nails and for 3-4 months for toe nails.
+
Topical Amrolfine cream for 6 months for finger nails and for 9 months for toe nails.
|
Intervention |
Urea application followed by CO2 laser ablation as an adjuvant to conventional therapy
|
Patient is given conventional therapy. Also, 10% preformulated urea cream is applied under occlusion followed by CO2 laser ablation of the affected nail. |
|
Inclusion Criteria
|
Age From |
18.00 Year(s) |
Age To |
60.00 Year(s) |
Gender |
Both |
Details |
1) Presence of fungus in nail clipping demonstrated by KOH/fungal culture
2) Dermoscopic findings suggestive of Onychomycosis
|
|
ExclusionCriteria |
Details |
1) Individuals with photosensitive dermatoses
2) Individuals with contraindications to CO2 laser therapy like Isotretinoin use within the previous six months, history of keloid formation or hypertrophic scarring, ongoing ultraviolet exposure, prior radiation therapy to treatment area, collagen vascular disease
3) Individuals with deranged bleeding time, clotting time, PT, APTT
4) Individuals on antiplatelet therapy (Aspirin, clopidogrel, ticagrelor, etc)
5) Pregnant and lactating women
|
|
Method of Generating Random Sequence
|
Other |
Method of Concealment
|
Not Applicable |
Blinding/Masking
|
Not Applicable |
Primary Outcome
|
Outcome |
TimePoints |
1) Clinical cure rate by nail examination and photographic evaluation
2) Mycological cure rate by KOH microscopic examination
3) Change in OSI (onychomycosis severity index score)
|
At baseline and at the end of 6 months (for finger nails) and 9 months (for toe nails)
|
|
Secondary Outcome
|
Outcome |
TimePoints |
1) To study adverse drug reactions due to topical and oral antifungal agents
2) To study post operative complications after nail avulsion
3) To study local complications after CO2 laser ablation
|
Change in the above parameters at the end of 6 months in finger nails and 9 months in toe nails |
|
Target Sample Size
|
Total Sample Size="321" Sample Size from India="321"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
Phase of Trial
|
N/A |
Date of First Enrollment (India)
|
10/05/2021 |
Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
Date of First Enrollment (Global) |
Date Missing |
Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
|
Not Applicable |
Recruitment Status of Trial (India) |
Not Yet Recruiting |
Publication Details
|
nil |
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
Brief Summary
|
Currently available treatment options for onychomycosis such as topical and systemic antifungals are often of limited efficacy, difficult to administer or associated with relevant side effects. The disease is notoriously difficult to treat due to the deep-seated nature of fungi within the nail plate, prolonged treatment requirements, poor patient adherence and frequent recurrences. Given the poor efficacy of currently available topical and systemic therapies, there is a renewed interest in exploring alternative treatment modalities for onychomycosis. Aim of the current study is to compare the benefit of adding urea application followed by CO2 laser ablation and nail avulsion as an adjuvant to conventional therapy in treatment of onychomycosis. |